# | Title | Journal | Year | Citations |
---|
1 | Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study | Lancet Neurology, The | 2009 | 617 |
2 | Pulmonary Hypertension Due to Left Heart Diseases | Journal of the American College of Cardiology | 2013 | 541 |
3 | A global view of pulmonary hypertension | Lancet Respiratory Medicine,the | 2016 | 523 |
4 | Pulmonary Hypertension in Chronic Lung Diseases | Journal of the American College of Cardiology | 2013 | 518 |
5 | Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension | Journal of the American College of Cardiology | 2009 | 463 |
6 | Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial | Lancet, The | 2019 | 406 |
7 | Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study | American Journal of Respiratory and Critical Care Medicine | 2005 | 345 |
8 | Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography | European Journal of Echocardiography | 2008 | 286 |
9 | Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study | European Heart Journal | 2017 | 244 |
10 | European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease | European Heart Journal Cardiovascular Imaging | 2015 | 186 |
11 | Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017 | European Heart Journal Cardiovascular Imaging | 2017 | 177 |
12 | Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease | European Heart Journal | 2018 | 140 |
13 | Echocardiography and lung ultrasonography for the assessment and management of acute heart failure | Nature Reviews Cardiology | 2017 | 138 |
14 | Pathophysiology of Takotsubo Syndrome | Journal of the American College of Cardiology | 2021 | 125 |
15 | COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension | European Respiratory Journal | 2022 | 124 |
16 | The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography | International Journal of Cardiology | 2009 | 123 |
17 | Lessons from contemporary trials of cardiovascular prevention and rehabilitation: A systematic review and meta-analysis | International Journal of Cardiology | 2017 | 121 |
18 | Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis | European Heart Journal | 2018 | 116 |
19 | Assessment of left ventricular function by different speckle-tracking software | European Journal of Echocardiography | 2010 | 111 |
20 | Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes | JACC: Cardiovascular Interventions | 2018 | 111 |
21 | Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry | Journal of Heart and Lung Transplantation | 2020 | 104 |
22 | Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial | Circulation | 2009 | 102 |
23 | Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting | Journal of the American College of Cardiology | 2019 | 101 |
24 | Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I K,slow1 and I to,f | FASEB Journal | 2008 | 99 |
25 | Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD | Journal of the American College of Cardiology | 2018 | 92 |
26 | Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization | Journal of the American College of Cardiology | 2018 | 89 |
27 | Body composition changes in patients with systolic heart failure treated with beta blockers: A pilot study | International Journal of Cardiology | 2006 | 88 |
28 | Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial | Lancet Respiratory Medicine,the | 2021 | 85 |
29 | Spatiotemporal Behavior of High Dominant Frequency During Paroxysmal and Persistent Atrial Fibrillation in the Human Left Atrium | Circulation: Arrhythmia and Electrophysiology | 2012 | 77 |
30 | Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease | Circulation: Cardiovascular Interventions | 2019 | 76 |
31 | Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction | JAMA Cardiology | 2019 | 75 |
32 | Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis | Heart | 2010 | 73 |
33 | Left main coronary artery disease: pathophysiology, diagnosis, and treatment | Nature Reviews Cardiology | 2018 | 73 |
34 | Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials | Blood Advances | 2018 | 66 |
35 | Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease | Circulation Journal | 2014 | 64 |
36 | Localisation of SCN10A Gene Product Nav1.8 and Novel Pain-Related Ion Channels in Human Heart | International Heart Journal | 2011 | 62 |
37 | Lipomatous hypertrophy of the interatrial septum: a commonly misdiagnosed mass often leading to unnecessary cardiac surgery | Heart | 2004 | 58 |
38 | Ethnic Differences in the Hypertensive Heart and 24-Hour Blood Pressure Profile | Hypertension | 1998 | 57 |
39 | 2019 APHRS expert consensus statement on three‐dimensional mapping systems for tachycardia developed in collaboration with HRS, EHRA, and LAHRS | Journal of Arrhythmia | 2020 | 57 |
40 | ORIGINAL ARTICLE: Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia | Clinical Endocrinology | 2010 | 54 |
41 | Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study | European Heart Journal | 2022 | 54 |
42 | Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings | European Heart Journal | 2007 | 53 |
43 | Breathlessness at rest is not the dominant presentation of patients admitted with heart failure | European Journal of Heart Failure | 2014 | 51 |
44 | Determinants of treatment plan implementation in multidisciplinary team meetings for patients with chronic diseases: a mixed-methods study | BMJ Quality and Safety | 2014 | 51 |
45 | Use of thrombectomy devices in primary percutaneous coronary intervention: A systematic review and meta-analysis | International Journal of Cardiology | 2013 | 50 |
46 | Predicting 3-Year Mortality After Percutaneous Coronary Intervention | JACC: Cardiovascular Interventions | 2014 | 50 |
47 | Tilt testing remains a valuable asset | European Heart Journal | 2021 | 50 |
48 | Safety of sapropterin dihydrochloride (6r–bh4) in patients with pulmonary hypertension | Experimental Lung Research | 2011 | 49 |
49 | Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension | Heart Failure Clinics | 2018 | 49 |
50 | Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2020 | 47 |